相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
Steven Herrine
Therapeutics and Clinical Risk Management (2016)
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
Pablo Labarga et al.
AIDS (2009)
Progressive Renal Tubular Dysfunction Associated with Long-Term Use of Tenofovir DF
Ei Kinai et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Population Pharmacokinetics of Tenofovir in HIV-1-Infected Pregnant Women and Their Neonates (ANRS 12109)
D. Hirt et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
The future of drug safety testing: expanding the view and narrowing the focus
James L. Stevens et al.
DRUG DISCOVERY TODAY (2009)
Endpoints of Therapy in Chronic Hepatitis B
Jordan J. Feld et al.
HEPATOLOGY (2009)
Recommendations for Identification and Public Health Management of Persons with Chronic Hepatitis B Virus Infection
Cindy M. Weinbaum et al.
HEPATOLOGY (2009)
The Natural History of Chronic Hepatitis B Virus Infection
Brian J. McMahon
HEPATOLOGY (2009)
Tenofovir-associated renal and bone toxicity
C. L. N. Woodward et al.
HIV MEDICINE (2009)
Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?
C. Foster et al.
HIV MEDICINE (2009)
Mitochondrial Tubulopathy in Tenofovir Disoproxil Fumarate-Treated Rats
Dirk Lebrecht et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Bone Pain Due to Fractures Revealing Osteomalacia Related to Tenofovir-Induced Proximal Renal Tubular Dysfunction in a Human Immunodeficiency Virus-Infected Patient
Serge Perrot et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
HEPATITIS B VIRUS (HBV) DRUGS IN PREGNANCY: FINDINGS FROM THE ANTIRETROVIRAL PREGNANCY REGISTRY
R. S. Brown et al.
JOURNAL OF HEPATOLOGY (2009)
Tenofovir renal toxicity targets mitochondria of renal proximal tubules
James J. Kohler et al.
LABORATORY INVESTIGATION (2009)
Tenofovir-associated Fanconi syndrome: Review of the FDA adverse event reporting system
Samir K. Gupta
AIDS PATIENT CARE AND STDS (2008)
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naive individuals in Thailand
Gail V. Matthews et al.
HEPATOLOGY (2008)
Acute Kidney Injury in Cirrhosis
Guadalupe Garcia-Tsao et al.
HEPATOLOGY (2008)
Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine - a Staccato trial substudy
Jintanat Ananworanich et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations
Jessica Tan et al.
JOURNAL OF HEPATOLOGY (2008)
Cause of death in individuals with chronic HBV and/or HCV infection, a nationwide community-based register study
Ann-Sofi Duberg et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Drug therapy - Hepatitis B virus infection
Jules L. Dienstag
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Is phosphatemia the best tool to monitor renal tenofovir toxicity?
Marie Essig et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2007)
Enzymatic therapeutic index of acyclovir -: Viral versus human polymerase γ specificity
Jeremiah W. Hanes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Epidemiology of hepatitis virus B and C
Margarita Dehesa-Violante et al.
ARCHIVES OF MEDICAL RESEARCH (2007)
Tenofovir-induced kidney injury
Michael D. Gitman et al.
EXPERT OPINION ON DRUG SAFETY (2007)
Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response
M. K. Jain et al.
JOURNAL OF VIRAL HEPATITIS (2007)
The significance of mitochondrial toxicity testing in drug development
James A. Dykens et al.
DRUG DISCOVERY TODAY (2007)
In vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cells
Francesc Vidal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
Marion G. Peters et al.
HEPATOLOGY (2006)
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
Guenther Schmutz et al.
AIDS (2006)
Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy
Marina Nunez et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2006)
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
Florian van Boemmel et al.
HEPATOLOGY (2006)
Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus
WE Delaney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Anti-hepatitis B virus efficacy of tendovir disoproxil fumarate in HIV-infected patients
Y Benhamou et al.
HEPATOLOGY (2006)
Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment
Brian P. Kearney et al.
CLINICAL PHARMACOKINETICS (2006)
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus
C Stephan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Acyclic nucleoside phosphonates: A key class of antiviral drugs
E De Clercq et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy
MJ Parsonage et al.
HIV MEDICINE (2005)
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir
MN Brunelle et al.
HEPATOLOGY (2005)
Antiviral drug-induced nephrotoxicity
H Izzedine et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Fanconi's syndrome in HIV+ adults:: Report of three cases and literature review
KE Earle et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Renal safety of tenofovir in HIV treatment-experienced patients
H Izzedine et al.
AIDS (2004)
Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus
GJ Dore et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Tenofovir Disoproxil Fumarate for the Treatment of Lamivudine-Resistant Hepatitis B
Alexander Kuo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection
F van Bömmel et al.
HEPATOLOGY (2004)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques
KKA Van Rompay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Tenofovir disoproxil fumarate in nucleoside-resistant HIV-1 infection a randomized trial
K Squires et al.
ANNALS OF INTERNAL MEDICINE (2003)
Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks
G Biesecker et al.
ANTIVIRAL RESEARCH (2003)
Renal lesions in HIV-1-positive patient treated with tenofovir
C Créput et al.
AIDS (2003)
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation
F Van Bömmel et al.
GASTROENTEROLOGY (2003)
An open-label study of tenofovir in HIV-1 and Hepatitis B virus co-infected individuals
M Nelson et al.
AIDS (2003)
Fanconi syndrome and renal failure induced by tenofovir: A first case report
D Verhelst et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Rapid communication: Acute renal failure associated with tenofovir: Evidence of drug-induced nephrotoxicity
S Coca et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2002)
Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study
RT Schooley et al.
AIDS (2002)
Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors
G Birkus et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Drug-induced liver disorders - Implications for drug development and regulation
N Kaplowitz
DRUG SAFETY (2001)
分享论文
